 |
 |
 |
| HRT RELATED ARTICLES |
| Title (Click for Details) |
Vol/Issue |
Page |
| Transdermals: The Skin as Part of a Drug Delivery System |
Vol. 15 No. 4 |
308 |
| Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review |
Vol. 15 No. 4 |
290 |
| The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women |
Vol. 14 No. 6 |
465 |
| Bioidentical Hormones in the News |
Vol. 14 No. 5 |
374 |
| The Role of Sex Hormones on Fibromyalgia Pain Mediators |
Vol. 14 No. 3 |
193 |
| Hormonal Influences in Prostate Cancer: An Update of a Complex Subject |
Vol. 14 No. 2 |
100 |
| Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study |
Vol. 14 No. 2 |
165 |
| Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing |
Vol. 13 No. 5 |
392 |
| Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding |
Vol. 13 No. 4 |
314 |
| Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison |
Vol. 13 No. 4 |
342 |
| Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia |
Vol. 13 No. 4 |
345 |
| The Physiologic Role and Use of Estriol |
Vol. 13 No. 4 |
270 |
| Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation |
Vol. 13 No. 4 |
280 |
| Estradiol 0.1% Vaginal Solution |
Vol. 12 No. 5 |
450 |
| PreScription: First Estriol, Then What? |
Vol. 12 No. 4 |
284 |
| PostScription: It Is Not Just What You Say…But How You Say It! |
Vol. 12 No. 4 |
375 |
| Estriol: Women's Choice vs. A Manufacturer's Greed |
Vol. 12 No. 4 |
286 |
| Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women |
Vol. 12 No. 4 |
295 |
| Progesterone and Traumatic Brain Injury: A Review of Literature |
Vol. 12 No. 4 |
310 |
| Marketing for Your Community |
Vol. 12 No. 4 |
338 |
| Calculations |
Vol. 12 No. 4 |
354 |
| Hormone Therapy: It's Time for a Second Opinion |
Vol. 12 No. 2 |
122 |
| PreScription: Bias, NAMS, and HRT |
Vol. 11 No. 4 |
266 |
| Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature |
Vol. 11 No. 4 |
269 |
| The History of Progesterone |
Vol. 11 No. 4 |
274 |
| Premarin: The Intriguing History of a Controversial Drug |
Vol. 11 No. 4 |
282 |
| Common Acronyms Used by Health Professionals Who Prescribe or Prepare Hormone Replacement |
Vol. 11 No. 4 |
288 |
| The Lived Experience of Perimenopausal and Menopausal Women Undergoing Treatment with Bioidentical Hormones |
Vol. 11 No. 4 |
292 |
| The Politics of Hormone Replacement Therapy |
Vol. 11 No. 4 |
278 |
| Case Report: Treatment of Labial Adhesions in a Child |
Vol. 11 No. 1 |
27 |
| The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States |
Vol. 10 No. 3 |
175 |
| Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update |
Vol. 10 No. 3 |
187 |
| Book Reviews: Awakening Athena: Resilience, Restoration, and Rejuvenation for Women |
Vol. 9 No. 4 |
252 |
| Book Reviews: Perfect Balance |
Vol. 9 No. 4 |
253 |
| Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome |
Vol. 9 No. 4 |
259 |
| Guidelines for Consulting with Patients about Bioidentical Hormone Replacement Therapy |
Vol. 9 No. 4 |
266 |
| Natural Progesterone Handout |
Vol. 9 No. 4 |
281 |
| PostScription: Women in Balance: A Cause Worth Advancing |
Vol. 9 No. 4 |
327 |
| Book Review: The Medical & Surgical Practice of NaProTECHNOLOGY |
Vol. 9 No. 1 |
5 |
| Book Review: HRT: The Answers. A Concise Guide for Solving the Hormone Replacement Therapy Puzzle |
Vol. 8 No. 6 |
412 |
| Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate? |
Vol. 8 No. 6 |
419 |
| The Salivary Hormone Profile in the Clinical Evaluation of Women |
Vol. 8 No. 6 |
427 |
| Book and Literature Reviews |
Vol. 8 No. 5 |
324 |
| Book and Literature Reviews |
Vol. 8 No. 4 |
244 |
| Estradiol 0.01% Wound Gel |
Vol. 8 No. 4 |
297 |
| Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy |
Vol. 8 No. 4 |
313 |
| Andropause: New Perspectives |
Vol. 8 No. 3 |
175 |
| Estrogen 0.625-mg/5-g Vaginal Gel |
Vol. 8 No. 3 |
185 |
| Testosterone Propionate 100-mg/mL in Oil Injection |
Vol. 8 No. 3 |
222 |
| Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2 |
Vol. 8 No. 2 |
96 |
| Women's Oral Health: Is There a Hormonal Link? |
Vol. 8 No. 1 |
10 |
| Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1 |
Vol. 8 No. 1 |
16 |
| Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations |
Vol. 7 No. 6 |
490 |
| Book and Literature Reviews |
Vol. 7 No. 5 |
324 |
| Patient Handout - Hormone Replacement Therapy |
Vol. 7 No. 5 |
339 |
| A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2 |
Vol. 7 No. 5 |
330 |
| A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 |
Vol. 7 No. 4 |
250 |
| Patient Satisfaction with Pharmacist Intervention and Consultation in HRT |
Vol. 7 No. 4 |
258 |
| Hydroxyprogesterone Caproate 250-mg/mL-in-Oil Injection |
Vol. 7 No. 4 |
299 |
| Sildenafil 25-mg Troches |
Vol. 7 No. 3 |
171 |
| Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection |
Vol. 7 No. 3 |
171 |
| Panel Discussion: Prohormones |
Vol. 7 No. 2 |
94 |
| Natural or Bioidentical Hormone Replacement: What makes the Difference? An Interview with Christopher B. Cutter, MD. |
Vol. 7 No. 1 |
24 |
| Andropause: A Review of Treatment Options |
Vol. 6 No. 6 |
458 |
| Satisfaction of Patients Using Bioidentical Hormones for Hormone Replacement Therapy |
Vol. 6 No. 5 |
377 |
| Custom-Compounded Micronized Hormones in a Slow-Release Capsule Matrix |
Vol. 6 No. 5 |
378 |
| A Review of Current Research on the Effects of Progesterone |
Vol. 6 No. 4 |
245 |
| The Hormonal Link to Breast Cancer: The Estrogen Matrix |
Vol. 6 No. 4 |
250 |
| Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women |
Vol. 6 No. 4 |
255 |
| Establishing an Andropause Practice |
Vol. 6 No. 4 |
259 |
| Dehydroepiandrosterone 25-mg/mL in Pluronic Lecithin Organogel |
Vol. 6 No. 4 |
293 |
| Dehydroepiandrosterone 25-mg/0.25-mL Sublingual Drops |
Vol. 6 No. 4 |
294 |
| Estradiol 0.5-mg Sublingual Troches |
Vol. 6 No. 4 |
295 |
| Estradiol 1-mg/0.1-mL Pluronic Lecithin Organogel |
Vol. 6 No. 4 |
296 |
| Estradiol 1-mg/0.1-g Topical Cream |
Vol. 6 No. 4 |
297 |
| Estriol 2-mg/mL, Estrone 0.25-mg/mL, and Estradiol 0.25-mg/mL Topical Solution |
Vol. 6 No. 4 |
298 |
| Estriol 2-mg/mL Topical Gel |
Vol. 6 No. 4 |
299 |
| Estriol 2-mg and Estradiol 0.5-mg/0.1-mL Sublingual Drops |
Vol. 6 No. 4 |
300 |
| Testosterone 25-mg in Oil Capsules |
Vol. 6 No. 4 |
301 |
| Testosterone 50-mg/mL Topical Gel |
Vol. 6 No. 4 |
302 |
| Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease |
Vol. 6 No. 3 |
171 |
| Tranilast 0.8% for Iontophoresis |
Vol. 6 No. 2 |
133 |
| Tranilast Topical 2% Penetrating Mixture |
Vol. 6 No. 2 |
134 |
| Bioidentical Hormone Replacement Therapy, Part 3, A Review of |
Vol. 6 No. 2 |
142 |
| Bioidentical Hormone Replacement Therapy, Part 2, A Review of |
Vol. 6 No. 1 |
50 |
| Hormone Replacement Therapy, Part 2: Estrogen Defined |
Vol. 5 No. 6 |
460 |
| The Science Behind Hormone Replacement Therapy, Part 1 |
Vol. 5 No. 6 |
462 |
| Flush Powder, No. 2 |
Vol. 5 No. 5 |
366 |
| Tincture of Black Cohosh |
Vol. 5 No. 5 |
366 |
| Lydia Pinkham's Vegetable Compound |
Vol. 5 No. 5 |
366 |
| Natural Hormone Replacement Therapy: What It Is and What Consumers Really Want |
Vol. 5 No. 5 |
332 |
| Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment |
Vol. 5 No. 5 |
336 |
| Bioidentical Hormones in the Treatment of Osteoporosis |
Vol. 5 No. 5 |
339 |
| The Value of Hormone Assessment |
Vol. 5 No. 5 |
342 |
| Estrogen Replacement: A Review of Current Literature |
Vol. 5 No. 5 |
346 |
| Treating Andropause: Prohormones and Hormone Metabolic Modifiers |
Vol. 5 No. 5 |
351 |
| Bioidentical Topical Progesterone: A Survey of Patients |
Vol. 5 No. 5 |
354 |
| Book Reviews: Hormone Replacement Therapy |
Vol. 5 No. 5 |
356 |
| Compounding in History: Treatment at the Change of Life |
Vol. 5 No. 5 |
365 |
| Estriol 2-mg/mL and Estradiol 0.5-mg/mL in Pluronic Lecithin Organogel (PLO) |
Vol. 5 No. 5 |
374 |
| Estriol 2-mg/g with Estradiol 0.5-mg/g Vaginal Cream |
Vol. 5 No. 5 |
375 |
| Libido Cream |
Vol. 5 No. 5 |
376 |
| Progesterone 50-mg/mL Clear Topical Solution |
Vol. 5 No. 5 |
377 |
| Progesterone Low-Potency 0.0065% Topical Cream |
Vol. 5 No. 5 |
378 |
| Sildenafil 1% Topical Cream |
Vol. 5 No. 5 |
379 |
| Testosterone 1-mg/0.1-mL Pluronic Lecithin Organogel (PLO) |
Vol. 5 No. 5 |
380 |
| Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches |
Vol. 5 No. 5 |
381 |
| Testosterone 25-mg/mL Clear Solution |
Vol. 5 No. 5 |
382 |
| Testosterone 2% Scalp Lotion |
Vol. 5 No. 5 |
383 |
| Natural Progesterone in Natural Hormone Replacement Therapy, The Role of |
Vol. 5 No. 3 |
218 |
| Infertility Care and the Role of the Compounding Pharmacist |
Vol. 5 No. 2 |
136 |
| Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 |
Vol. 5 No. 1 |
52 |
| "Natural" Isomolecular Hormone Replacement: An Evidence-Based Medicine Approach |
Vol. 4 No .6 |
414 |
| Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1 |
Vol. 4 No .6 |
421 |
| Book Reviews: Women's Health |
Vol. 4 No .6 |
424 |
| Hormone Replacement Therapy: Selected Recent References |
Vol. 4 No .6 |
426 |
| Testosterone Deficiency in Men: New Treatments for Andropause |
Vol. 4 No .6 |
429 |
| Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists |
Vol. 4 No .6 |
432 |
| Estriol and Estradiol 2.5-mg, Progesterone 50-mg, and Testosterone 1-mg Capsules |
Vol. 4 No .6 |
458 |
| Estriol and Estradiol 1.25, 2.5, and 5-mg (BiEst) Capsules |
Vol. 4 No .6 |
459 |
| Estrogen 0.625-mg/5-g Vaginal Gel |
Vol. 4 No .6 |
460 |
| Progesterone Cycle Pack 35/50/75/100-mg Capsules |
Vol. 4 No .6 |
461 |
| Testosterone 1-mg/0.1-mL Nasal Spray |
Vol. 4 No .6 |
462 |
| Testosterone 1-mg/0.1-mL in a PLO Gel |
Vol. 4 No .6 |
463 |
| Testosterone 1-mg/0.1-mL Topical Vaginal/Scrotal Spray |
Vol. 4 No .6 |
464 |
| Triple Estrogen 2.5-mg/0.1-mL PLO |
Vol. 4 No .6 |
465 |
| Triple Estrogen 2.5-mg/0.1-mL Sublingual Drops |
Vol. 4 No .6 |
466 |
| Triple Estrogen 2.5-mg Tablet Triturates |
Vol. 4 No .6 |
467 |
| Estrogen Use in Dogs: Indications and Complications |
Vol. 4 No .6 |
468 |
| Natural Estrogens: A Review of the Primary Literature |
Vol. 4 No. 2 |
110 |
| The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops |
Vol. 3 No. 6 |
461 |
| Linguet Base (Soft Lozenge) |
Vol. 3 No. 6 |
462 |
| Sorbitol Based Hard Lozenges |
Vol. 3 No. 6 |
462 |
| Sucrose Based Hard Lozenges |
Vol. 3 No. 6 |
462 |
| Polyethylene Glycol (PEG) Troches (Soft Lozenges) |
Vol. 3 No. 6 |
463 |
| Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges) |
Vol. 3 No. 6 |
463 |
| Chewable Lozenges |
Vol. 3 No. 6 |
464 |
| Interview: Katharina Dalton, MD: Progesterone and Related Topics |
Vol. 3 No. 5 |
332 |
| Top Ten HRT Compound Preparations |
Vol. 3 No. 5 |
342 |
| Wilson's Syndrome and T3 Therapy |
Vol. 3 No. 5 |
344 |
| Case Reports: Long-Term Effects of Topical Progesterone Cream Application; Progesterone Suppositories for PMS |
Vol. 3 No. 5 |
352 |
| Andropause: Annotated Citations from the Literature |
Vol. 3 No. 5 |
355 |
| Women's Health Book Reviews |
Vol. 3 No. 5 |
357 |
| Planning and Marketing a Natural HRT Patient Seminar |
Vol. 3 No. 5 |
360 |
| Lubricating Jelly Formula |
Vol. 3 No. 5 |
388 |
| Estriol 0.2-mg/mL in Pluronic Lecithin Organogel |
Vol. 3 No. 5 |
392 |
| Ethinyl Estradiol 0.2-mg Gelatin Troches |
Vol. 3 No. 5 |
393 |
| Progesterone 50-mg/mL Topical Gel |
Vol. 3 No. 5 |
394 |
| Progesterone 100-mg/mL Sublingual Drops |
Vol. 3 No. 5 |
395 |
| Progesterone 100-mg Semisolid-Fill, Hard-Gelatin Capsules |
Vol. 3 No. 5 |
396 |
| Progesterone 10% Topical Cream |
Vol. 3 No. 5 |
397 |
| Progesterone 200-mg/mL in Pluronic Lecithin Organogel |
Vol. 3 No. 5 |
398 |
| Testosterone 1-mg Buccal Troches |
Vol. 3 No. 5 |
399 |
| Triple Estrogen 2.5-mg, Progesterone 100-mg and Testosterone 1-mg Capsules |
Vol. 3 No. 5 |
400 |
| Triple Estrogen 2.5-mg Slow-Release Capsules |
Vol. 3 No. 5 |
401 |
| Estradiol 5-mg/mL-in-Oil Injection |
Vol. 3 No. 4 |
300 |
| Tri-Est 2.5-mg/mL Aqueous Injection |
Vol. 3 No. 4 |
304 |
| Quantitation of Testosterone-Cypionate-in-Oil Injection using High Performance Liquid Chromatography |
Vol. 3 No. 4 |
314 |
| Progesterone 100-mg/mL Veterinary Injection |
Vol. 3 No. 3 |
223 |
| Quantitation of Testosterone in Suspension using High Performance Liquid Chromatography |
Vol. 3 No. 3 |
239 |
| Men's Health: Practical Solutions to a Profoundly Underrated Health-Care Crisis |
Vol. 3 No. 2 |
76 |
| Male Impotency and the Compounding Pharmacist |
Vol. 3 No. 2 |
80 |
| Medication Combinations for Penile Injections |
Vol. 3 No. 2 |
81 |
| Natural Testosterone: Hormone of the Heart |
Vol. 3 No. 2 |
88 |
| Case Report: Testosterone Supplementation in a Vasectomy Patient |
Vol. 3 No. 2 |
101 |
| Natural HRT: Corrective Measures When the System Goes Down |
Vol. 3 No. 2 |
109 |
| Dehydroepiandrosterone 50-mg Capsules |
Vol. 3 No. 2 |
131 |
| Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection |
Vol. 3 No. 2 |
134 |
| Sildenafil Citrate 25-mg Sublingual Troches |
Vol. 3 No. 2 |
135 |
| Testosterone-Menthol Eutectic Ointment (2% Testosterone) |
Vol. 3 No. 2 |
137 |
| Testosterone 10-mg Troches |
Vol. 3 No. 2 |
138 |
| Testosterone 10-mg/0.1-mL Sublingual Drops |
Vol. 3 No. 2 |
139 |
| Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags |
Vol. 3 No. 2 |
156 |
| Quantitation of Testosterone Propionate in an Injection Using High Performance Liquid Chromatography |
Vol. 3 No. 2 |
158 |
| In Vitro Transdermal Delivery and Stability of Liposome-Encapsulated Prostaglandin E1 |
Vol. 3 No. 2 |
160 |
| HRT Marketing Tip |
Vol. 3 No. 1 |
37 |
| Progesterone 200-mg/mL in Grapeseed-Oil Suspension |
Vol. 2 No. 6 |
442 |
| Triple Estrogen 2.5-mg Capsules (Lactose Free) |
Vol. 2 No. 6 |
445 |
| Treatment of Skin Aging with Topical Estrogens |
Vol. 2 No. 4 |
270 |
| Essential Truths About HRT |
Vol. 2 No. 1 |
10 |
| Interview on HRT: Christiane Northrup, MD, FACOG |
Vol. 2 No. 1 |
12 |
| HRT and the Continuing Education of Health Care Professionals |
Vol. 2 No. 1 |
18 |
| Estrogen and Breast Cancer: Is There a Link? |
Vol. 2 No. 1 |
21 |
| Estrogen in the Treatment and Prevention of Alzheimer's Disease |
Vol. 2 No. 1 |
24 |
| Reviews: Books on HRT |
Vol. 2 No. 1 |
30 |
| Estradiol 1-mg Vaginal Suppositories |
Vol. 2 No. 1 |
48 |
| Estradiol Topical Gel |
Vol. 2 No. 1 |
49 |
| Estradiol Vaginal Cream (0.2%) |
Vol. 2 No. 1 |
50 |
| Estradiol Vaginal Gel (0.2%) |
Vol. 2 No. 1 |
51 |
| Methyltestosterone 6-mg/g Gel |
Vol. 2 No. 1 |
52 |
| Progesterone Enema 100- and 200-mg/mL |
Vol. 2 No. 1 |
53 |
| Progesterone-Estradiol-Testosterone in Oil Capsules |
Vol. 2 No. 1 |
54 |
| Progesterone in Oil Capsules |
Vol. 2 No. 1 |
55 |
| Progesterone Nasal Spray (2%) |
Vol. 2 No. 1 |
56 |
| Progesterone Oral Suspension (40-mg/mL) |
Vol. 2 No. 1 |
57 |
| Progesterone 3% Vaginal Gel |
Vol. 2 No. 1 |
58 |
| Progesterone Troches (100-mg, Soft) |
Vol. 2 No. 1 |
59 |
| Progesterone Troches (300-mg, Hard) |
Vol. 2 No. 1 |
60 |
| Progesterone Troches (400-mg, Soft) |
Vol. 2 No. 1 |
61 |
| Progesterone 200-mg Buccal Tablets |
Vol. 2 No. 1 |
62 |
| Progesterone 200-mg Linguets (Soft) |
Vol. 2 No. 1 |
63 |
| Progesterone Vaginal Cream (5%) |
Vol. 2 No. 1 |
64 |
| Progesterone Vaginal Suppositories (Fatty Acid Base) |
Vol. 2 No. 1 |
65 |
| Progesterone Vaginal Suppositories (Polyethylene Glycol Bases) |
Vol. 2 No. 1 |
66 |
| Testosterone Propionate Gel |
Vol. 2 No. 1 |
67 |
| Testosterone Propionate 100-mg/6 mL Cream |
Vol. 2 No. 1 |
68 |
| Testosterone Propionate 2% Ointment |
Vol. 2 No. 1 |
69 |
| Testosterone 0.625-mg Troches |
Vol. 2 No. 1 |
70 |
| Estriol Solution for Iontophoresis for Acne Scars |
Vol. 1 No. 6 |
411 |
| Assaying Progesterone in Extemporaneously Prepared Suppositories |
Vol. 1 No. 5 |
339 |
| The Changing Body |
Vol. 1 No. 3 |
144 |
| Progesterone 100-mg in Peanut-Oil Capsules |
Vol. 1 No. 3 |
182 |
| Triple Estrogen 2.5-mg in Oil Capsules |
Vol. 1 No. 3 |
185 |
| Triple Estrogen 2.5-mg in Lactose Capsules |
Vol. 1 No. 3 |
186 |
| Triple Estrogen 2.5-mg Semisolid-Filled Hard-Gelatin Capsules |
Vol. 1 No. 3 |
187 |
| HDDM Hard Troche |
Vol. 1 No. 1 |
29 |
| HDDM Soft Troche |
Vol. 1 No. 1 |
30 |
| HDDM Sugar Troche |
Vol. 1 No. 1 |
30 |